Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Emerging Therapies
In this activity, experts in adult and paediatric hepatology and gastroenterology explore practical strategies and evidence-based tools to diagnose and facilitate tailored treatment decision-making for primary biliary cholangitis (PBC) and progressive familial intrahepatic cholestasis (PFIC). <br />
<br />
Supported by: Ipsen Biopharmaceuticals, Inc. <br />
<br />
Organized by: PeerVoice<br />
<br />
CME Provider: USF Health <br />
<br />
Link: <a href="https://cme.peervoice.com/140202451_1/140202451_1_p1/stage1reg?CountryI… />
<br />
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.